The dose-dependent PP2A activation and anti-proliferative functions of miR-300 may be upregulated by BMM signals, which induces growth arrest and expansion of the G0–G1 quiescent CML LSCs. Here, PTPA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.